Advanced Prostate Cancer VL

Oligometastatic and Oligo-progressive Prostate Cancer: What Are the Clinicians Needs in This Situation - Oliver Sartor

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Interview with Oliver Sartor from the APCCC

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Nuclear Specialist - Stefano Fanti

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Radiopharmaceuticals in Prostate Cancer - Stefano Fanti

Epidemiology and Treatment of Advanced Prostate Cancer in India - Vedang Murthy

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

APCCC 2017: Interview With Howard Soule

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage A Look at the Prostate Cancer Foundation Its History and Contributions to Medical Progress: Interview with Stuart Holden

ADT Impact on Cardiovascular Health - Jehonathan Pinthus

Details
The impact of androgen deprivation therapy (ADT) on cardiovascular health Biographies: Thomas E. Keane Jehonathan H. Pinthus, MD, PhD, FRCSC is a surgical oncologist-urologist and ssociate Professor in the Department of Surgery Division of Urology McMaster University. He is heading a basic and translational research laboratory at McMaster University and his research interests relates to the patien...

Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans

Details
Patient-Reported Outcomes (PRO): Personalizing Care in Clinical Practice Biography: Alicia Morgans, MD, MPH Related Content: Tools for predicting patient-reported outcomes (PROs): Optimizing Use in Clinical Practice

Standardization for Prostate Cancer Radical Prostatectomy Reporting for Locally Advanced Disease - Mark A Rubin

Details
Mark A. Rubin, MD is a recognized world leader in the area of prostate cancer genomics and pathology and openned his presentation on the recently published " Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual". He went on to discuss the significant changes included in this publication and its move towards consensus. (Presentation in 8:57)...

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

Details
In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy. Biography: Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone P...

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

Details
Protecting Patients From Harm - Active Surveillance Biographies: Thomas E Keane Laurence Klotz, MD Related Content: Active Surveillance in PCa+ Active surveillance in prostate cancer: a critical review
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe